Converge Bio vs Pepticom
Converge Bio vs Pepticom, compared side by side on 23 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Converge Bio is on 56/100 and Pepticom on 55/100.
Where each one leads
Converge Bio
- agent readiness: 44/100 against 21/100
- domain rating: 28/100 against 24/100
- headcount: 51 against 16
- headcount growth: +220.3% against -1.8%
- LinkedIn following: 6,830 against 3,160
Pepticom
- funding raised: $7.6M against $5.5M
At a glance
| Measure | Converge Bio | Pepticom |
|---|---|---|
| What it is | Computational platform using LLMs trained on biological and chemical data for drug discovery. | AI platform for accelerating novel peptide therapeutic discovery and development. |
| Category | Life Sciences, Generative AI, Large Language Models (LLMs), Pharmaceutical | Healthcare, Drug Discovery, Clinical Development, Peptide Drugs |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2023 | 2011 |
| Headquarters | San Francisco, United States | Jerusalem, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Converge Bio | Pepticom |
|---|---|---|
| Employees | 51 | 16 |
| Headcount growthLast 12 months | +220.3% | -1.8% |
| Total funding | $5.5M | $7.6M |
| Latest round | Seed | Funding Round |
| LinkedIn followers | 6,830 | 3,160 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Converge Bio | Pepticom |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 55/100 |
| Traction | 51/100 | 47/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 36/100 | 33/100 |
| Quality | 62/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Converge Bio | Pepticom |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Framer | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager, Microsoft Clarity | Google Analytics 4, Google Tag Manager |
| Support stack | HubSpot | Not detected |
| Open source | Yes | No |
| Self-hostable | Yes | No |
Converge Bio vs Pepticom: common questions
Which is better, Converge Bio or Pepticom?
On our 0-100 score Converge Bio rates higher (56/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 23 data points above: read the rows that match what you are buying for.
How do Converge Bio and Pepticom compare on the numbers?
Converge Bio leads on agent readiness (44/100 against 21/100), domain rating (28/100 against 24/100), headcount (51 against 16), headcount growth (+220.3% against -1.8%), LinkedIn following (6,830 against 3,160). Pepticom leads on funding raised ($7.6M against $5.5M).
Read the full Converge Bio review and pricing or the Pepticom review and pricing. You can also browse other Converge Bio alternatives we track.